
|Slideshows|October 9, 2018
- Managed Healthcare Executive November 2018 Issue
- Volume 28
- Issue 11
Eight Top Oncology Drug Approvals
Author(s)Erin Johanek, PharmD, RPh
New cancer drugs continue to offer patients hope. Here are eight of them.
Advertisement
Articles in this issue
about 7 years ago
Looser Restrictions on HRAs on the Horizonover 7 years ago
Nine Ways to Deal with Escalating Drug Costsover 7 years ago
Time to Address ‘Financial Toxicity’ of Cancer Treatmentover 7 years ago
CAR T-cell Therapy: How Payers are Responding to Huge Price Tagsover 7 years ago
Medical Foods Strive for Insurance Coverageover 7 years ago
New Chiefs at MCOs: 4 Positions You May Want to Addover 7 years ago
Eight Predictions for Cancer Care in 10 Yearsover 7 years ago
Is Precision Medicine Worth the Hype? Oncologists Weigh InNewsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























